- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SGLT-2 inhibitor
Total 104330 results
-
NovartisCompletedType 2 Diabetes MellitusTaiwan, Philippines, Italy, Germany, Romania, Hungary, Australia, Korea, Republic of, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Nagaoka Red Cross HospitalKurume UniversityUnknownType 2 Diabetes MellitusJapan
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
TakedaCompleted
-
TakedaCompletedType 2 Diabetes Mellitus
-
GlaxoSmithKlineCompleted
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Tanta UniversityCompletedNeonatal HyperbilirubinemiaEgypt
-
PegBio Co., Ltd.RecruitingType 2 Diabetes Mellitus (T2DM)China, Taiwan, Hong Kong
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus (T2DM)
-
AstraZenecaRecruiting
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
University Hospital TuebingenWithdrawn
-
University of LiverpoolAstraZeneca; Clinical Practice Research DatalinkActive, not recruitingType 2 Diabetes MellitusUnited Kingdom
-
TakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Japan, Czechia, Hungary, Poland, Spain
-
Peking Union Medical College HospitalChinese Academy of SciencesUnknown
-
Yaounde Central HospitalCompletedType 2 Diabetes MellitusCameroon
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
BHV PharmaIntegriumCompletedDiabetes Mellitus, Type 2 | Type 2 Diabetes MellitusUnited States
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
-
VeroScienceCompletedType 2 Diabetes Mellitus
-
SanofiCompleted
-
Laval UniversityMerck Sharp & Dohme LLCCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, Mexico, Germany, Greece, Argentina, India, Australia
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
TakedaCompleted
-
TakedaCompleted
-
TakedaCompleted
-
Samsung Medical CenterJW PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
-
Henan Cancer HospitalQilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.Not yet recruitingHER-2 Negative Breast Cancer
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
BayerActive, not recruiting
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingType 2 Diabetes MellitusChina
-
SanofiCompletedType 2 Diabetes MellitusChina
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain